 |
1 Product |  |
0 Diseases | | 1 Product |
|
2 Trials |  |
111 News |  |
| «12 |
- Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Enrollment change: PRO-810: A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=9, Terminated, Sponsor: Titan Pharmaceuticals
N=16 --> 9
- ||||||| Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Trial completion: A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction (clinicaltrials.gov) - Oct 22, 2012
P3, N=287, Completed, Sponsor: Titan Pharmaceuticals
N=16 --> 9 Active, not recruiting --> Completed
- ||||||| Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Trial completion: PRO-807: Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=62, Completed, Sponsor: Titan Pharmaceuticals
Active, not recruiting --> Completed Suspended --> Completed